J., Vaughan, C
Novo Nordisk Patients Seeking Upgrade CagriSema Patients already on semaglutide (Wegovy) who need greater weight loss can potentially upgrade to CagriSema within the Novo Nordisk ecosystem once approved, leveraging the same GLP-1 component plus added amylin agonism
Analysis of risk factors and development of a predictive model for new vertebral fractures subsequent to percutaneous kyphoplasty in patients with single-segment osteoporotic vertebral compression fractures Fumai Zhang, Jiayi Chen, Guang Li, Bin Wu, Wentao Cai BMC Musculoskeletal Disorders .2026;[Epub] CrossRef 2
doi:10.2147/cmar.s45746
In one study, participants who followed an exercise programme maintained their weight even a year after the programme ended, while those who relied on medication alone were more likely to regain weight.[8] Current guidance from the World Health Organisation recommends aiming for at least 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity per week, plus two sessions of muscle-strengthening exercises.[9] Research shows that people who receive continued professional support after losing weight are more likely to maintain their results long-term.[10] When you come off GLP-1 medication, appetite, routine and motivation can all begin to shift, and working with a healthcare professional, dietitian or fitness specialist can help you navigate this transition
It was FDA-approved for obesity in 2014
